Recombinant CD3E (Visilizumab Biosimilar) antibody

Catalog No. ABIN7598094

This Humanized Chimeric antibody specifically detects CD3E (Visilizumab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant CD3E (Visilizumab Biosimilar) antibody (ABIN7598094)

Target: CD3E (Visilizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Grade: Research Grade

Product Details anti-CD3E (Visilizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Visilizumab Biosimilar Antibody

Specificity: T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG2

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD3E (Visilizumab Biosimilar)

Target: CD3E (Visilizumab Biosimilar)

Alternative Name: Visilizumab Biosimilar

Target Type: Biosimilar

Background: T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain

UniProt: P07766

CAS-No: 219716-33-3